Fresh Rounds

Converge Bio Inc. funding

Converge Bio Inc., a biotechnology company based in Claymont, DE (founded 2024), filed a Form D with the SEC on April 28, 2026 and reported $25M raised.

Amount raised$25M
Offering size$25M
Filed with the SECApril 28, 2026
First saleSeptember 24, 2025
IndustryBiotechnology
SecuritiesEquity
LocationClaymont, DE
Founded2024
Entity typeCorporation
Investors so far19
Minimum investment—
Revenue rangeDecline to Disclose

Other health care rounds in Delaware